AstraZeneca PLC (LON:AZN)
11,794
-162 (-1.35%)
Sep 12, 2025, 5:42 PM BST
AstraZeneca Revenue
AstraZeneca had revenue of $14.46B USD in the quarter ending June 30, 2025, with 11.74% growth. This brings the company's revenue in the last twelve months to $56.50B, up 15.00% year-over-year. In the year 2024, AstraZeneca had annual revenue of $54.07B with 18.03% growth.
Revenue (ttm)
$56.50B
Revenue Growth
+15.00%
P/S Ratio
4.43
Revenue / Employee
$599.16K
Employees
94,300
Market Cap
182.89B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 54.07B | 8.26B | 18.03% |
Dec 31, 2023 | 45.81B | 1.46B | 3.29% |
Dec 31, 2022 | 44.35B | 6.93B | 18.53% |
Dec 31, 2021 | 37.42B | 10.80B | 40.58% |
Dec 31, 2020 | 26.62B | 2.23B | 9.16% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |
Oxford Nanopore Technologies | 204.69M |
AstraZeneca News
- 3 hours ago - AstraZeneca (AZN) Halts $271M UK Investment Amid Economic Uncertainty - GuruFocus
- 3 hours ago - AstraZeneca's £200m blow to Labour as pharma giant scraps major investment - This is Money
- 3 hours ago - AstraZeneca pauses £200m expansion in Cambridge - Evening Standard
- 3 hours ago - AstraZeneca pauses £200m Cambridge investment - BBC
- 4 hours ago - AstraZeneca (AZN) Halts $271M Investment in UK Amid Uncertainty - GuruFocus
- 5 hours ago - AstraZeneca (AZN) Halts Major Investment in UK Research Facility - GuruFocus
- 5 hours ago - AstraZeneca pauses £200mn Cambridge investment amid UK pharma uncertainty - Invezz
- 6 hours ago - AstraZeneca follows Merck’s pullback in Britain: report - Seeking Alpha